G-21

G-21

Biomaterial solutions and procedures for orthopedic and spine surgery, focused on vertebral consolidation and articular rehabilitation.

  • Edit
DateInvestorsAmountRound
*

N/A

Buyout
Total Funding000k
More about G-21
Made with AI
Edit

Established in 2009 by entrepreneurs from the medical and pharmaceutical sectors, G21 develops and supplies solutions for orthopedic and spine surgery. The company's product portfolio consists of biomaterials and procedures designed for vertebral consolidation and articular functional rehabilitation.

Operating from its base in northern Italy, G21 serves the medical market, specifically targeting therapeutic treatments for orthopedic patients. The business model centers on the creation of these specialized medical solutions, catering to a niche within the broader healthcare industry. The primary clients are likely hospitals, surgical centers, and orthopedic specialists who utilize these products in surgical procedures.

Keywords: biomaterials, orthopedic surgery, spine surgery, vertebral consolidation, articular rehabilitation, medical devices, medical solutions, orthopedics, healthcare, surgical procedures

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads